GenericAll countries · Checked
Generic Liraglutide: Generic Saxenda and Victoza Options
Yes, generic liraglutide exists. In the US, Teva's generic Saxenda was approved by the FDA on August 27, 2025 and launched the next day, and the UK and the EU have approved products too.
Is there a generic Saxenda?
Yes. The generic name is liraglutide, and approved generic products exist in the US, the UK and the EU.
Generic nameLiraglutide
US generic SaxendaTeva, approved August 27, 2025
UK generic for weightBiolide (Biocon)
EU generic for weightAblymico, authorised July 15, 2026
Based on FDA and EMA records and company announcements. Saxenda is made by Novo Nordisk.
Even with a generic, what you pay depends on your country and your cover.
See what weight loss injections cost in each countryWant the dose steps? See Saxenda dosing.
Generic nameGeneric SaxendaGeneric VictozaUKEUSame drug?DosePriceSafetyOther drugsFAQ
Generic liraglutide
Liraglutide is the active ingredient in both Saxenda and Victoza. It is a GLP-1 medicine injected under the skin once a day.
Saxenda is the weight management brand, and Victoza is the type 2 diabetes brand. The ingredient is the same, but the approved use and the doses are not.
That is why generics come in two kinds. One follows Saxenda for weight management, and the other follows Victoza for diabetes.
What the medicine does and who it is for is covered in Liraglutide (Saxenda, Victoza).
Generic Saxenda
On August 27, 2025, the FDA approved Teva's liraglutide injection as a generic of Saxenda.
Teva announced the US launch on August 28, 2025. The company called it the first generic GLP-1 approved for weight loss.
US generic Saxenda
MakerTeva
FDA approvalAugust 27, 2025
Launch announcedAugust 28, 2025
Approved forObesity in adults and in people 12 and older over 60 kg, and overweight adults with a weight-related condition
The generic is used with a lower-calorie diet and more physical activity, to lose weight and keep it off.
It is not for use together with another GLP-1 medicine. The rule is the same as for Saxenda.
Generic Victoza
Victoza is a diabetes medicine, not a weight loss one, and so are its generics.
On June 24, 2024, Teva announced the US launch of an authorized generic of Victoza.
On December 23, 2024, the FDA approved Hikma's liraglutide injection (18 mg/3 mL) as the first generic referencing Victoza. It is for type 2 diabetes in adults and in children aged 10 and over.
If your goal is weight loss, the approved route is generic Saxenda, not generic Victoza.
Generic liraglutide in the UK
Biocon launched generic liraglutide in the UK, announced on February 28, 2025. It had approval from the UK regulator, the MHRA.
UK Biocon products
BiolideChronic weight management
Liraglutide BioconDiabetes
Biocon said this made it the first generics company approved for liraglutide in a major regulated market.
Who can get weight loss injections on the NHS is in GLP-1 cover and savings in the UK.
Generic liraglutide in the EU
In the EU, two products were authorised on July 15, 2026.
EU products authorised July 15, 2026
AblymicoWeight management, reference medicine Saxenda
Liraglutide STADAType 2 diabetes, reference medicine Victoza
The EMA calls both of them hybrid medicines. The ingredient is the same, but the way it is made differs.
Saxenda's ingredient is made with living cells, and Ablymico's is made by chemical processes.
Ablymico is authorised for adults with a BMI of 30 or more, adults with a BMI of 27 to 30 and a weight-related problem, teenagers aged 12 and over above 60 kg, and children aged 6 to under 12 with obesity who weigh at least 45 kg.
Is generic Saxenda the same as Saxenda?
A generic is approved as the same as the brand: the same active ingredient, the same strength and the same way of giving it. The name and the maker differ.
The FDA approved the Teva product for the same uses as Saxenda.
The Saxenda pen holds 3 mL of a 6 mg/mL solution and delivers 0.6, 1.2, 1.8, 2.4 or 3 mg. The brand label sets the dose steps.
You can find the steps in Saxenda dosing.
Generic Saxenda dose
The Saxenda label recommends 3 mg a day. You start at 0.6 mg a day for one week and go up each week until you reach 3 mg.
Teenagers aged 12 and over who cannot tolerate 3 mg may be moved down to 2.4 mg.
If you miss a dose, carry on with the next scheduled dose and never take an extra one. If more than 3 days have passed since your last dose, the US label restarts you at 0.6 mg a day.
Your prescriber sets your dose, including when you switch to a generic.
Generic Saxenda price
The price of generic Saxenda depends on your country, how it is supplied and your cover.
There is a country-by-country comparison in GLP-1 weight loss injection prices, and a monthly cost estimate in the weight loss injection cost calculator.
Generic Saxenda safety
In the US, Saxenda and Victoza carry a boxed warning about thyroid C-cell tumors. It comes from animal studies.
You should not take it if you or a family member has had medullary thyroid cancer, or if you have multiple endocrine neoplasia type 2.
In the adult Saxenda trials, nausea affected 39.3% of people (13.8% on placebo), diarrhea 20.9% (9.9%), constipation 19.4% (8.5%) and vomiting 15.7% (3.9%).
Generic versions of other weight loss drugs
Semaglutide is the ingredient in Ozempic and Wegovy, and each has its own page: generic Ozempic and the Wegovy generic name.
Tirzepatide has no approved generic yet. See Mounjaro generic name and generic tirzepatide.
The wider picture is in generic GLP-1 drugs.
Generic liraglutide FAQ
Is there a generic Saxenda?
Yes. The US has Teva's product, the UK has Biolide and the EU has authorised Ablymico.
When did generic Saxenda come out?
In the US, the launch was announced on August 28, 2025. In the UK, Biocon announced its launch on February 28, 2025.
Can I use generic Victoza for weight loss?
No. Victoza and its generics are approved for type 2 diabetes. For weight loss, the approved product is generic Saxenda.
What is the generic name for Saxenda?
Liraglutide. Saxenda and Victoza both contain it.
Do I change my dose if I switch to a generic?
Your prescriber decides that. Do not change it on your own.
Keep reading
Liraglutide (Saxenda, Victoza)
This page follows FDA and EMA records and company announcements, and is updated when an approval changes. See how we check our pages.
Update log
: First published.
Sources
FDA, Saxenda prescribing information (Novo Nordisk).
FDA, 2025 first generic drug approvals.
Teva, generic Saxenda approval and launch announcement.
Teva, authorized generic of Victoza launch.
FDA, first generic referencing Victoza.
EMA, Ablymico and Liraglutide STADA.
Biocon, UK liraglutide launch.
GLP1 Note is an independent information site. Which product you use is decided by your prescriber.